These findings establish key targets (Bmp4, Serpine1, Ptgs2, Gata6) as central to SMA’s multisystem pathology, with TNF-α hyperactivation as the critical upstream driver [143]. The gene discussed is TNF; the disease is proximal spinal muscular atrophy.